Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
BOSTON, April 11, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA ), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome's platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
- BOSTON, April 11, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA ), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome's platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
- These assets will be integrated into Ginkgo Ag Biologicals Services , established with the acquisition of a Bayer agricultural biologicals R&D facility in 2022, and will expand Ginkgo's proprietary unified metagenomics database.
- AgBiome has successfully commercialized multiple biological products, including the Howler and Theia product lines, which are not included in the acquisition.
- Michael Miille, Ginkgo Fellow: "We are so excited to bring AgBiome's incredible strain and metagenomic collection into Ginkgo.